墨西哥青少年与青年甲型肝炎血清流行病学:2012年全国健康与营养调查分析
基于2012年墨西哥全国健康与营养调查的1581份随机血清样本,加权估计青少年(10-19岁)和青年(20-25岁)的甲型肝炎病毒(HAV)血清阳性率分别为58.8%和83.0%,总体为69.3%,提示全国处于中等地方性流行水平,且与社会经济地位、年龄、地区和城乡居住地相关。
要点
- 青少年HAV血清阳性率58.8%(95%CI: 53.4-64.1),青年83.0%(95%CI: 75.3-88.7),总体69.3%(95%CI: 64.8-73.4)。
- 低社会经济地位者HAV血清阳性的aOR为4.09,中等为2.31(均以高社会经济地位为参照)。
- 南部地区aOR为2.12(以中部墨西哥为参照),农村aOR为2.25(以城市为参照)。
核心结论
- 墨西哥全国HAV血清阳性率处于中等地方性流行水平,边缘化人群中血清阳性率较高且存在地区差异。
研究设计与样本
- 基于2012年墨西哥全国健康与营养调查数据,随机选取1581份血清样本,加权估计HAV血清阳性率(95%CI)及其与社会人口学因素的关联。
主要发现
- 总体加权HAV血清阳性率为69.3%(95%CI: 64.8-73.4),青少年为58.8%(95%CI: 53.4-64.1),青年为83.0%(95%CI: 75.3-88.7)。
- 10岁时46.7%(95%CI: 33.9-60.0)血清阳性,15岁时52.8%(95%CI: 36.5-68.5)血清阳性。
- 低社会经济地位aOR=4.09、中等社会经济地位aOR=2.31(均以高社会经济地位为参照);青少年vs青年的aOR=0.29;南部vs中部墨西哥aOR=2.12;农村vs城市aOR=2.25。
关键数值与推荐
- 低社会经济地位者HAV血清阳性的aOR=4.09(以高社会经济地位为参照)。
- 中等社会经济地位者HAV血清阳性的aOR=2.31(以高社会经济地位为参照)。
- 青少年相比青年的HAV血清阳性aOR=0.29。
- 南部地区相比中部墨西哥的HAV血清阳性aOR=2.12。
- 农村相比城市的HAV血清阳性aOR=2.25。
临床怎么用
- 研究结果提示需持续改善卫生与教育,并考虑在更易感地区开展疫苗接种,以应对有症状疾病的负担。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To describe hepatitis A virus (HAV) seroprevalence and associated factors in adolescents (10-19 years) and young adults (20-25 years) in different Mexican regions, using 2012 National Health and Nutrition Survey data. A random selection of 1581 serum samples was analyzed. Weighted HAV seroprevalence with 95% confidence intervals (95%CI) and its association with sociodemographic factors were estimated. Mean weighted HAV seroprevalence was 69.3% (95%CI: 64.8-73.4) overall, with 58.8% (95%CI: 53.4-64.1) in adolescents and 83.0% (95%CI: 75.3-88.7) in young adults. By age of 10, 46.7% (95%CI: 33.9-60.0) were seropositive and by age of 15, 52.8% (95%CI: 36.5-68.5), corresponding to intermediate endemicity nationally. Factors associated with HAV seropositivity (adjusted odds ratio, aOR) included: lower socioeconomic status (SES) (aOR = 4.09 for low and aOR = 2.31 for medium versus high SES), older age (aOR = 0.29 for adolescents versus young adults), living in the South (aOR = 2.12 versus Central Mexico) or in rural areas (aOR = 2.25 versus urban areas). Regional differences and increased seroprevalence of HAV in marginalized populations present an important public health issue, as a relatively large proportion of young adults are susceptible to infection. The burden of symptomatic disease must be addressed further to support specific programs of continued sanitation and education improvement, and the possibility of vaccination in more susceptible regions.
引用
- López-Gatell H, García-García L, Echániz-Avilés G, et al. Hepatitis A seroprevalence in adolescents and young adults in Mexico: A 2012 National Health and Nutrition Survey analysis. Vaccine. 2018. PMID: 30337174. doi:10.1016/j.vaccine.2018.10.037
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。